Evidence map›Paper›PMID 32031300›Full record

ArticleJournal of diabetes investigation2020

Association of glucose tolerance status with pancreatic β- and α-cell mass in community-based autopsy samples of Japanese individuals: The Hisayama Study.

Jun Inaishi, Yoshifumi Saisho, Yoichiro Hirakawa, Daigo Yoshida, Jun Hata, Naoko Mukai, Yuusuke Watanabe, Yoshinao Oda, Hiroshi Itoh, Toshiharu Ninomiya

Open access · goldAbstract read
In one paragraph

Article in Journal of diabetes investigation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Jun InaishiDepartment of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.ORCID https://orcid.org/0000-0003-3725-9107
Yoshifumi SaishoDivison of Endocrinology, Metabolism and Nephrology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Yoichiro HirakawaDepartment of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Daigo YoshidaDepartment of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Jun HataDepartment of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Naoko MukaiDepartment of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.ORCID https://orcid.org/0000-0002-3385-9116
Yuusuke WatanabeDivison of Endocrinology, Metabolism and Nephrology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Yoshinao OdaDepartment of Anatomic Pathology, Pathological Sciences, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Hiroshi ItohDivison of Endocrinology, Metabolism and Nephrology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Toshiharu NinomiyaDepartment of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.ORCID https://orcid.org/0000-0003-1345-9032
Kyushu University · JPKeio University · JP

Funding

Health and Labour Sciences Research Grants of the Ministry of Health, Labour and Welfare of Japan H29-Junkankitou-Ippan-003Health and Labour Sciences Research Grants of the Ministry of Health, Labour and Welfare of Japan H30-Shokuhin-[Sitei]-005Novo Nordisk Pharma LtdThe Japan Agency for Medical Research and Development JP19dk0207025, JP19ek0210082, JP19ek0210083The Japan Agency for Medical Research and Development JP19ek0210080The Japan Agency for Medical Research and Development JP19ek0210082The Japan Agency for Medical Research and Development JP19ek0210083The Japan Agency for Medical Research and Development JP19fk0108075The Japan Agency for Medical Research and Development JP19km0405202, JP19ek0210080, JP19fk0108075The Ministry of Education, Culture, Sports, Science and Technology of Japan JP15K09399, JP17K09114, JP17K09113, JP17K01853The Ministry of Education, Culture, Sports, Science and Technology of Japan JP16H02692The Ministry of Education, Culture, Sports, Science and Technology of Japan JP16H05850, JP17H04126, JP18H02737The Ministry of Education, Culture, Sports, Science and Technology of Japan JP17H04126The Ministry of Education, Culture, Sports, Science and Technology of Japan JP17K01853The Ministry of Education, Culture, Sports, Science and Technology of Japan JP17K09113The Ministry of Education, Culture, Sports, Science and Technology of Japan JP17K09114The Ministry of Education, Culture, Sports, Science and Technology of Japan JP18H02737The Ministry of Education, Culture, Sports, Science and Technology of Japan JP18K07565, JP18K08488, JP18K09412, JP19K07890The Ministry of Education, Culture, Sports, Science and Technology of Japan JP18K08488The Ministry of Education, Culture, Sports, Science and Technology of Japan JP18K09412The Ministry of Education, Culture, Sports, Science and Technology of Japan JP18K16245The Ministry of Education, Culture, Sports, Science and Technology of Japan JP18K17382The Ministry of Education, Culture, Sports, Science and Technology of Japan JP18K17925, JP18K17382, JP18K16245The Ministry of Education, Culture, Sports, Science and Technology of Japan JP19K07890
6 · The paper itself

Abstract

AIMS/

introductionChanges in histologically quantified β- and α-cell mass during the development of glucose intolerance have not been fully elucidated. The aim of the present study was to explore differences in β- and α-cell mass according to the glucose tolerance status. MATERIALS AND

methodsAutopsy samples from a total of 103 individuals (40 with normal glucose tolerance, 31 with prediabetes and 32 with type 2 diabetes mellitus) who underwent a 75-g oral glucose tolerance test within 5 years before death were selected from 643 community-based autopsy samples collected from 2002 to 2016. Fractional β-cell area (BCA) and α-cell area were quantified with Image Pro Plus software. Associations of BCA and α-cell area with glucose tolerance status were assessed using a linear regression analysis, and Spearman's correlation coefficients between glycemic markers and β-cell function were estimated.

resultsThe mean values of BCA decreased significantly with worsening glucose tolerance status (mean ± standard error 1.85 ± 0.10% in normal glucose tolerance, 1.59 ± 0.11% in prediabetes and 1.17 ± 0.11% in type 2 diabetes mellitus, P for trend < 0.001), whereas there was no significant association between α-cell area and glucose tolerance status. BCA was inversely correlated with fasting and 2-h plasma glucose levels during oral glucose tolerance test and glycated hemoglobin measurement, and positively correlated with disposition index (all P < 0.01).

conclusionsβ-Cell mass decreased significantly with worsening glucose tolerance, from the stage of prediabetes, in the Japanese population. Prevention of declining β-cell mass before the onset of glucose intolerance is important to reduce the burden of type 2 diabetes mellitus.

Indexed as

AgedAutopsyBiomarkersBlood GlucoseCross-Sectional StudiesDiabetes Mellitus, Type 2FemaleFollow-Up StudiesGlucagon-Secreting CellsGlucose IntoleranceHumansInsulin-Secreting CellsJapanMalePrediabetic StatePrognosisBiomarkersBlood GlucosePrediabetesType 2 diabetes mellitusβ-Cell mass

Identifiers

PMID32031300
PMCPMC7477504
OpenAlexW3012923512

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.